Eva Domingo-Domenech, MD on How ADCETRIS May Impact Existing Treatment in sALCL?

Eva Domingo-Domenech, MD of Institut Català d’Oncologia – Hospitalet discusses ADCETRIS for Treatment of Adult Patients with Previously Untreated sALCL: How ADCETRIS
may impact the existing sALCL treatment landscape?